Skip to main content
Skip to main content
ELV logo

Elevance Health Inc. (ELV) Stock Analysis

$397.54 -$0.915 (-0.23%) |Exceptional · 86
Elevance Health Inc. (ELV) bottom line: signals are mixed — the Council read leans Bullish Lean (60/100) while the AI fundamental score is 86/100 (grade A+); the two lenses disagree, so weigh the breakdown below. Strongest signal: Valuation strong · Biggest watch-out: Izzy Englander bearish.
MCap: $86.2B| P/E Ratio: 16.3| Vol: 194.5K| Target: $392.07 (-1.4%)| 52-wk range: $274.84 – $436.24
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Elevance Health Inc. (ELV) trades at $397.54 with AI Score 86/100 (Grade A+). Elevance Health Inc. is a health benefits company connecting individuals to the care and resources needed for healthier lives. Market cap: $86.2B, Sector: Healthcare.

Price as of Aug 20, 2026 · Last analyzed: May 10, 2026
Elevance Health Inc. is a health benefits company connecting individuals to the care and resources needed for healthier lives. Serving approximately 118 million people, they offer a broad portfolio of medical, digital, pharmacy, and behavioral health solutions.

ELV stock analysis for 2026: Analysts have set a consensus price target of $392.07 for Elevance Health Inc., suggesting 1.4% downside from the current price of $397.54. The AI MoonshotScore is 86/100, indicating a strong bullish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.

Watch the ELV film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Bullish Lean 60/100 · B+

ELV: 2/3 scored disciplines lean bullish. Dominant signal: Valuation strong.

How is this calculated? →
MoonshotScore · Growth Potential · 86/100
Business Quality
Strong Is this a genuinely good business?
Financial Safety
Neutral Could this blow up on me?
Valuation
Strong Am I paying a fair price?
Growth Durability
Strong Is the growth real and likely to last?
Momentum
Moderate Is the market already moving on this?
Legends Council · 5 Legends + Moon AI
Ken Griffin
Neutral
Izzy Englander
Bearish
Seth Klarman
Neutral
Moon AI
Neutral
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Neutral
Margin of Safety
Undervalued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Why this analysis is different

  • A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Elevance Health Inc. (ELV) Healthcare & Pipeline Overview

CEOGail Koziara Boudreaux
Employees104,200
HeadquartersIndianapolis, IN, US
IPO Year2001

Elevance Health Inc. provides health benefits and related services to approximately 118 million people, offering a diverse portfolio of medical, digital, and pharmacy solutions. Formerly known as Anthem, the company focuses on connecting consumers with comprehensive care across the healthcare journey, positioning it as a major player in the managed healthcare sector.

Data Provenance | Financial Data Quantitative Analysis NYSE Analysis: May 10, 2026

What Is the Investment Thesis for ELV?

As of May 10, 2026 — figures reflect the data available on that date.

Elevance Health presents a compelling investment thesis based on its significant market presence, serving approximately 118 million people, and its diversified portfolio of health solutions. The company's focus on digital health and integrated care models positions it well to capitalize on evolving healthcare trends. With a P/E ratio of 16.3 and a dividend yield of 1.81%, Elevance Health offers a blend of value and income. Key growth catalysts include expanding its digital health offerings and increasing penetration in government-sponsored programs. Potential risks include regulatory changes and increasing competition in the health benefits market. The company's ability to maintain its gross margin of 23.2% and drive further efficiencies will be crucial for sustained profitability.

Based on FMP financials and quantitative analysis

ELV Key Highlights

Elevance Health serves approximately 118 million people through its diverse portfolio of health solutions.

  • The company's P/E ratio stands at 16.3, indicating a reasonable valuation relative to earnings.
  • Elevance Health's gross margin is 23.2%, reflecting its ability to manage healthcare costs and generate revenue effectively.
  • The company offers a dividend yield of 1.81%, providing investors with a steady income stream.
  • Elevance Health's beta of 0.50 suggests lower volatility compared to the broader market.

Who Are ELV's Competitors?

ELV is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
CVS CVS Health Corporation $93.65 +0.00% $119B 70
GSK GSK plc $51.96 -1.74% $104B 61
CI Cigna Corporation $274.41 -1.10% $72.5B 78
REGN Regeneron Pharmaceuticals, Inc. $835.15 -0.68% $86.0B 90
COR Cencora, Inc. $316.79 -0.10% $61.6B 80
ANTM Elevance Health Inc. $482.58 +2.71% $115B 48
HUM Humana Inc. $381.21 +0.84% $45.8B 51
CNC Centene Corporation $64.14 -0.86% $31.7B 65

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are ELV's Key Strengths?

Large membership base of approximately 118 million people.

  • Diversified portfolio of medical, digital, pharmacy, and behavioral health solutions.
  • Strong brand recognition and reputation in the health insurance industry.
  • Experienced management team with a proven track record.

What Are ELV's Weaknesses?

Exposure to regulatory changes and healthcare reform.

  • Dependence on government-sponsored programs.
  • Competition from other large health insurers and managed care organizations.
  • Potential for rising healthcare costs to impact profitability.

What Could Drive ELV Stock Higher?

Expansion of digital health platforms to improve member engagement and access to care.

  • Strategic partnerships with healthcare providers to enhance value-based care models.
  • Potential regulatory changes that could expand access to government-sponsored healthcare programs.
  • Continued focus on data analytics to improve care management and personalize member experiences.

What Are the Key Risks for ELV?

Increasing competition from other health insurers and managed care organizations.

  • Rising healthcare costs and potential for medical loss ratio to exceed expectations.
  • Regulatory changes and healthcare reform that could impact the company's business model.
  • Cybersecurity threats and data breaches that could compromise member information.

What Are the Growth Opportunities for ELV?

  • Growth opportunity 1: Expanding Digital Health Offerings: Elevance Health can further expand its digital health offerings, including telehealth, remote monitoring, and digital therapeutics. By leveraging technology, Elevance Health can improve access to care, enhance patient engagement, and reduce healthcare costs. This includes personalized wellness programs and virtual care solutions, creating a competitive advantage.
  • Growth opportunity 2: Increasing Penetration in Government-Sponsored Programs: Elevance Health can increase its penetration in government-sponsored programs such as Medicare and Medicaid. These programs represent a large and growing market, driven by demographic trends and government initiatives to expand access to healthcare. By offering competitive plans and focusing on quality of care, Elevance Health can attract more members and increase its revenue. This includes partnering with states to manage Medicaid populations and expanding its Medicare Advantage offerings.
  • Growth opportunity 3: Strategic Acquisitions and Partnerships: Elevance Health can pursue strategic acquisitions and partnerships to expand its service offerings and geographic reach. This includes acquiring companies with expertise in specialized areas such as behavioral health, pharmacy benefits management, and data analytics. By integrating these capabilities, Elevance Health can offer a more comprehensive suite of services and improve its competitive position. These partnerships can also help Elevance Health enter new markets and reach new customer segments.
  • Growth opportunity 4: Enhancing Data Analytics Capabilities: Elevance Health can enhance its data analytics capabilities to improve care management, personalize member experiences, and reduce healthcare costs. By leveraging data analytics, Elevance Health can identify high-risk members, predict healthcare needs, and develop targeted interventions. This includes using data to optimize care pathways, improve medication adherence, and prevent hospital readmissions. The insights gained from data analytics can also inform product development and pricing strategies.
  • Growth opportunity 5: Expanding Value-Based Care Arrangements: Elevance Health can expand its value-based care arrangements with providers, aligning incentives to improve quality and reduce costs. Value-based care models reward providers for delivering better outcomes and lower costs, rather than simply providing more services. By partnering with providers in these arrangements, Elevance Health can improve care coordination, reduce unnecessary utilization, and enhance the overall value of healthcare. This includes shared savings programs and bundled payment arrangements.

What Are ELV's Competitive Advantages?

  • Scale: Serves approximately 118 million people, providing significant economies of scale.
  • Brand Recognition: Well-established brand with a long history in the health insurance industry.
  • Network Effects: Large network of providers, offering members access to a wide range of healthcare services.
  • Regulatory Expertise: Deep understanding of healthcare regulations and compliance requirements.

What Does ELV Do?

Elevance Health Inc., formerly known as Anthem, Inc., was founded in 1944 and rebranded in June 2022 to reflect its broader focus on health beyond traditional insurance. Headquartered in Indianapolis, Indiana, the company operates as a health benefits provider, offering a wide array of services including medical, digital, pharmacy, behavioral, clinical, and care solutions. Elevance Health supports consumers, families, and communities by connecting them to the necessary care, support, and resources to lead healthier lives. The company serves approximately 118 million people through its various health plans and related offerings. Elevance Health's evolution from a traditional health insurer to a comprehensive health solutions provider underscores its commitment to addressing the holistic health needs of its members. Its offerings include employer-sponsored plans, individual plans, and government-sponsored programs like Medicare and Medicaid. Elevance Health competes with other major players in the health insurance and managed care industry, leveraging its scale and diverse service offerings to maintain a competitive edge.

What Products and Services Does ELV Offer?

  • Provides medical benefits plans to individuals, families, and employer groups.
  • Offers digital health solutions to improve access to care and enhance patient engagement.
  • Manages pharmacy benefits to ensure cost-effective and appropriate medication use.
  • Provides behavioral health services to address mental health and substance use disorders.
  • Offers clinical and care solutions to improve health outcomes and reduce healthcare costs.
  • Connects members to the care, support, and resources they need to lead healthier lives.
  • Administers government-sponsored healthcare programs, including Medicare and Medicaid.

How Does ELV Make Money?

  • Generates revenue through premiums paid by members for health insurance coverage.
  • Earns fees for managing pharmacy benefits and providing other healthcare services.
  • Manages healthcare costs through negotiated rates with providers and utilization management programs.
  • Invests in technology and innovation to improve efficiency and enhance member experience.

What Industry Does ELV Operate In?

Elevance Health operates within the dynamic and highly regulated healthcare industry. The market is characterized by increasing demand for comprehensive health solutions, driven by an aging population and rising healthcare costs. The industry is also undergoing significant digital transformation, with companies investing in telehealth, data analytics, and personalized medicine. Elevance Health competes with other major health insurers and managed care organizations. The company's focus on integrated care models and digital health positions it to capitalize on these trends and maintain a competitive edge in the evolving healthcare landscape.

Who Are ELV's Key Customers?

  • Individuals and families seeking health insurance coverage.
  • Employers offering health benefits to their employees.
  • Government agencies administering Medicare and Medicaid programs.
  • Healthcare providers participating in Elevance Health's network.
AI Confidence: 83% Updated: May 10, 2026

Elevance Health Inc. Financial Trajectory

Elevance Health Inc. (ELV) reported $50.47B in revenue for Q2 2026, reflecting 0.6% growth compared to the prior quarter. The company recorded net income of $1.46B, with diluted EPS of $6.71. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this large-cap Healthcare company. Across the four most recent quarters, ELV averaged $5.63 in diluted EPS.

Company Profile

Elevance Health Inc. operates in the Medical - Healthcare Plans industry within the Healthcare sector. It is headquartered in Indianapolis, US. The company is led by CEO Gail Koziara Boudreaux. ELV has traded publicly since 2001.

How Elevance Health Inc. Is Valued

Elevance Health Inc. carries a market capitalization of $86.2B, placing it in the large-cap category. Relative to its peer group, ELV's quantitative score of 86/100 is above the peer average of 76/100.

ROE 12%

Key Financial Metrics

Return on equity for Elevance Health Inc. stands at 12.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 4.2%, showing how much profit it generates from its asset base. ELV trades at a trailing price-to-earnings ratio of 16.26, below the Healthcare sector average of ~23x. Its free cash flow yield is 7.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.48 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 6.1%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 8/9

Financial Health

Elevance Health Inc.'s Piotroski F-Score is 8/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 3.14 places it in the safe zone, indicating low near-term bankruptcy risk.

6/8 beats

Earnings Track Record

Elevance Health Inc. has beaten Wall Street's EPS estimate in 6 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 7.2% above estimates on average.

FY2026 est

Forward Outlook

Wall Street analysts project Elevance Health Inc. revenue of about $197.09B for fiscal 2026, with EPS near $27.14. The estimate reflects 14 contributing analysts.

Net buying

Insider Activity

Over the past six months, Elevance Health Inc. insiders filed 15 SEC Form 4 transactions — 5 sales and 10 purchases. On net that is roughly 4K shares acquired (about $542K) — insiders putting money in tends to read as conviction.

ELV Financials

ELV earnings history & estimates →

Fundamental Snapshot

Revenue Growth (FY)
+12.6%
Net Income Growth (FY)
-5.3%
EPS Growth (FY)
-2.4%
Free Cash Flow Growth (FY)
-30.3%
P/E (TTM)
16.3
Return on Equity (TTM)
+12.0%
Current Ratio
1.5
EV/EBITDA (TTM)
11.9

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Large membership base of approximately 118 million people.
  • Diversified portfolio of medical, digital, pharmacy, and behavioral health solutions.
  • Strong brand recognition and reputation in the health insurance industry.
  • Experienced management team with a proven track record.

Bear Case

  • Exposure to regulatory changes and healthcare reform.
  • Dependence on government-sponsored programs.
  • Competition from other large health insurers and managed care organizations.
  • Potential for rising healthcare costs to impact profitability.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q2 2026 $50.47B $1.46B $6.71
Q1 2026 $50.18B $1.76B $8.00
Q4 2025 $49.75B $547M $2.47
Q3 2025 $50.71B $1.19B $5.32

Based on FMP financials and quantitative analysis

ELV Latest News

ELV Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ELV.

Price Targets

Consensus target: $392.07

ELV MoonshotScore

86/100

What does this score mean?

The MoonshotScore rates ELV 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.

Latest Elevance Health Inc. Analysis

Leadership: Gail Koziara Boudreaux

President and Chief Executive Officer

Gail Koziara Boudreaux has served as the President and CEO of Elevance Health Inc. since 2017. Before joining Elevance Health, she was the CEO of UnitedHealthcare, a division of UnitedHealth Group. She also held executive leadership positions at Blue Cross Blue Shield of Illinois. Boudreaux has a distinguished career in the healthcare industry, with a focus on improving access to care and promoting health equity. She holds a bachelor's degree in economics from Dartmouth College and an MBA from Harvard Business School.

Track Record: Under Gail Koziara Boudreaux's leadership, Elevance Health has transformed from a traditional health insurer to a comprehensive health solutions provider. She spearheaded the company's rebranding from Anthem to Elevance Health, reflecting its broader focus on health beyond insurance. Boudreaux has also overseen significant investments in digital health and value-based care, positioning the company for long-term growth and success. Her tenure has been marked by a commitment to innovation and a focus on improving the health and well-being of Elevance Health's members.

What Investors Ask About Elevance Health Inc. (ELV) — Healthcare

What does the AI Score mean for ELV?

ELV holds an AI Score of 86/100 (Grade: A+). This is an educational research signal, not a buy or sell recommendation. Elevance Health Inc. is a health benefits company connecting individuals to the care and resources needed for healthier lives. Serving approximately 118 million people, they offer a broad portfolio …

What does Elevance Health Inc. do?

Elevance Health Inc. operates as a health benefits company, providing a range of medical, digital, pharmacy, behavioral, clinical, and care solutions to approximately 118 million people. The company connects consumers, families, and communities to the care, support, and resources they need to lead healthier lives. Elevance Health's offerings include employer-sponsored plans, individual plans, and government-sponsored programs like Medicare and Medicaid.

What do analysts say about ELV stock?

Analysts generally view Elevance Health favorably, citing its strong market position, diversified service offerings, and growth potential. Key valuation metrics such as P/E ratio and dividend yield suggest a reasonable valuation relative to earnings and a steady income stream for investors. Analysts also highlight the company's focus on digital health and value-based care as positive drivers for future growth.

What are the main risks for ELV?

Elevance Health faces several key risks, including increasing competition from other health insurers and managed care organizations, rising healthcare costs and the potential for the medical loss ratio to exceed expectations, regulatory changes and healthcare reform that could impact the company's business model, and cybersecurity threats and data breaches that could compromise member information.

How does Elevance Health Inc. navigate regulatory approval processes?

Elevance Health operates in a highly regulated industry and must comply with various federal and state regulations related to healthcare and insurance. The company has a dedicated regulatory affairs team that monitors regulatory developments, engages with policymakers, and ensures compliance with applicable laws and regulations.

How does Elevance Health Inc. address healthcare affordability for its members?

Elevance Health addresses healthcare affordability for its members through various strategies, including negotiating competitive rates with providers, implementing utilization management programs to reduce unnecessary healthcare spending, offering a range of health plan options with different cost-sharing arrangements, and promoting preventive care to improve health outcomes and reduce the need for costly medical interventions.

What are the key factors to evaluate for ELV?

Elevance Health Inc. (ELV) holds an AI score of 86/100 (high). P/E: 16.3x vs the S&P 500's ~20-25x. Analysts target $392.07 (-1%). Not financial advice.

How frequently does ELV data refresh on this page?

ELV's price was last updated on Aug 20, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven ELV's recent stock price performance?

Elevance Health Inc. (ELV) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Large membership base of approximately 118 million people. See the News tab for the latest drivers. Past performance does not predict future results.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on publicly available sources and may be subject to change.
  • Financial data is as of the latest available reporting period.
Data Sources

Popular Stocks

More Stocks We Cover